Effectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugs.

about

Effectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugs.

Item

http://www.wikidata.org/entity/Q40571341

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effectiveness of a systematic ...... ted with anti-TNF alpha drugs.

@en

type

Item

label

Effectiveness of a systematic ...... ted with anti-TNF alpha drugs.

@en

prefLabel

Effectiveness of a systematic ...... ted with anti-TNF alpha drugs.

@en

P1476

Effectiveness of a systematic ...... ted with anti-TNF alpha drugs.

@en

P2093

Antonio Gracia-Pérez

http://www.w3.org/2001/XMLSchema#string

Joaquín Borrás-Blasco

http://www.w3.org/2001/XMLSchema#string

Md Elvira Casterá

http://www.w3.org/2001/XMLSchema#string

Sergio Fernandez-Martinez

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort.

Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm data.

Routinely measuring and reporting pneumococcal vaccination among immunosuppressed rheumatology outpatients: the first step in improving quality

Vaccination rates among the general adult population and high-risk groups in the United States

HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus.

Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis

Vaccine strategies to enhance immune responses in the aged.

The risk of infections with biologic therapies for rheumatoid arthritis.

How to manage the infectious risk under anti-TNF in inflammatory bowel disease.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14712598.2016.1218844

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Xavier Cortés

P577

2016-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27537179

http://www.w3.org/2001/XMLSchema#string

P921

TNF inhibitor